C&GTACEPDVendorDynamicsPMSafetyMedicalservicesPhaseIIPatientRecruitmentKick-OffmeetingSmartsheetCBOClinicalOperationsProtocolDevelopmentPhaseIDecentralizedtrialsFIHstudyCRARetentionStrategyInfectionDiseaseFeasibilityCTOOverburnA-TeamBiometricsEUCTRCTLSSUBDMRAVEProposalOrg.chartTimesheetICHR3PharmacodynamicsSponsorTCPharmacokineticsOncologyHematologyStrategyINDsubmissionVEEVANeuroscienceResourceMaginPhaseIIIRarediseaseClinicaldevelopmentSAPC&GTACEPDVendorDynamicsPMSafetyMedicalservicesPhaseIIPatientRecruitmentKick-OffmeetingSmartsheetCBOClinicalOperationsProtocolDevelopmentPhaseIDecentralizedtrialsFIHstudyCRARetentionStrategyInfectionDiseaseFeasibilityCTOOverburnA-TeamBiometricsEUCTRCTLSSUBDMRAVEProposalOrg.chartTimesheetICHR3PharmacodynamicsSponsorTCPharmacokineticsOncologyHematologyStrategyINDsubmissionVEEVANeuroscienceResourceMaginPhaseIIIRarediseaseClinicaldevelopmentSAP

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
  1. C&GT
  2. ACE
  3. PD
  4. Vendor
  5. Dynamics
  6. PM
  7. Safety
  8. Medical services
  9. Phase II
  10. Patient Recruitment
  11. Kick-Off meeting
  12. Smartsheet
  13. CBO
  14. Clinical Operations
  15. Protocol Development
  16. Phase I
  17. Decentralized trials
  18. FIH study
  19. CRA
  20. Retention Strategy
  21. Infection Disease
  22. Feasibility
  23. CTO
  24. Overburn
  25. A-Team
  26. Biometrics
  27. EUCTR
  28. CTL
  29. SSU
  30. BDM
  31. RAVE
  32. Proposal
  33. Org. chart
  34. Timesheet
  35. ICH R3
  36. Pharmacodynamics
  37. Sponsor TC
  38. Pharmacokinetics
  39. Oncology
  40. Hematology
  41. Strategy
  42. IND submission
  43. VEEVA
  44. Neuroscience
  45. Resource
  46. Magin
  47. Phase III
  48. Rare disease
  49. Clinical development
  50. SAP